Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Medarex, Pfizer deal

MEDX signed a 10-year deal with PFE covering the discovery and development of up to 50 antibody products. MEDX

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE